Introduction
Tissue-or cell type-specific promoters have been used extensively to drive expression of Crerecombinase, thereby allowing selective knockout of a "floxed" target gene (reviewed in (16) ).
This strategy allows one to examine the consequences of cell-selective loss-of-function while preserving the function of the target gene in other cells and tissues. To target the vasculature, the murine endothelial receptor tyrosine kinase (Tie2) (15) and rat smooth muscle myosin heavy chain (Smmhc)(11) regulatory sequences have been extensively employed; and many examples of endothelial-and smooth muscle-specific deletion have been reported (see as examples refs: 1-3; 7; 8; 10; 13). The tissue-specificity of these regulatory sequences have been extensively studied suggesting they can be used to effectively generate endothelial-and smooth musclespecific knockout models (4; 6; 11; 12; 14; 15; 17) . In our effort to generate mice lacking PPARγ (Pparg) specifically in endothelial and vascular muscle cells we determined that both the Tie2 and Smmhc regulatory sequences are able to drive expression of Cre-recombinase in the female and male germ line, respectively. This causes the conversion of the floxed allele to a null allele in the germline which is transmitted to offspring which can result in global deletion irrespective of their Cre-recombinase genotype. mice, a PCR product with lesser intensity than either the floxed or wildtype (wt) alleles, and confirmed as the null allele by DNA sequencing, was evident ( Figure 1B, lanes 1-2) . The null allele was detected in genomic DNA of 76% of the mice, all of which were eCre + . In the second generation, PPARG F/+ eCre + mice were backcrossed to PPARG F/F mice generating 172 offspring.
Results

Endothelial Cell Targeted Mice
The PPARG null allele was detected in genomic DNA from 42% of the offspring, 31% of which To investigate this "eCre-independent" gene deletion further, F2 offspring were retrospectively separated into two groups based on the gender of the eCre + transmitting parent ( Figure 1C ). The null allele was never detected in genomic DNA from eCre -F2 offspring when it was transmitted through the male germ line ( Figure 1B , lanes 4, 7-10), indicating that the Tie2 promoter is not active in the male germ line. However, when the eCre + allele was transmitted through the female germ line, the null allele was detected in genomic DNA from 100% of PPARG Figure 2B ).
Smooth Muscle Cell Targeted Mice
We employed a similar strategy for the generation of PPARG F/F Smmhc-Cre + (sCre 
Discussion
We generated two models in which we attempted to selectively ablate the Pparg gene in the endothelium and vascular muscle, respectively. Our data suggests that the Smmhc promoter drives Cre-recombinase expression in the male germ line prior to the second meiotic division, resulting in the global deletion of the paternally inherited floxed allele, even in sCre -offspring.
This hypothesis is supported by data showing that SMMHC protein is present in primary spermatocytes at the zygotene to early diplotene stage (5). On the contrary, there was no evidence of male germline expression of the eCre + transgene. The eCre + transgene however was apparently expressed in the female germline. It is interesting to note that in many instances (40%), the null allele was detected at an intensity similar to that of the wildtype allele in F2 mice genotyped as PPARG F/+ eCre -when eCre + (and the Pparg wildtype allele) was transmitted by the female. This efficient conversion of the paternal floxed allele suggests that there may be retention of Cre-recombinase activity in the early embryo after fertilization.
Our data regarding activation of Cre-recombinase expression by the Tie2 and Smmhc in the germ line are in agreement with other studies using other floxed genes (7; 9) strongly suggesting our observations are not an aberration caused by Pparg locus. Our data raise some concerns regarding study design and control selection which must be considered when interpreting the results of experiments where the breeding scheme was either not detailed or the gender of the Cre-transmitting parent considered. Unfortunately, it is difficult to assess if this has adversely affected published studies as often the details of the intercross between floxed and Cre mice are not very thorough and the amount of genotyping information provided is minimal.
Consequently, can this problem be avoided? In terms of the Tie2-Cre model and other Cre-recombinase models with similar problems, complications arising from germ line Crerecombinase activity can be avoided by transmitting the transgene through the male germ line.
Recall, none of the Cre -offspring from mice bred in this manner had the null allele and there was no expression of the null allele at the mRNA if the mice were Cre -. The situation is more complicated for the smooth muscle-specific promoter, and other Cre-recombinase transgenes found to be expressed in both the male and female germ lines. In this case, mice expected to be should be taken that only Gene F/null Cre -littermates are selected as controls.
In conclusion, we have shown that activation of Cre expression by the Tie2 and Smmhc promoters occurs in the female and male germ lines respectively. We believe that both these promoters can be used successfully to develop vascular-specific knockout mice providing that germ line expression of Cre is taken into account in design of the study. If investigators are uncertain whether their favorite Cre-recombinase transgene is expressed in germ cells, they should make an effort to ensure that their genotyping assay can detect and distinguish between the wildtype, floxed and null allele, and to keep accurate records of the genotypes of the offspring. Designing an RT-PCR assay that also detects an expressed null allele can also provide an important diagnostic tool to determine if faithful cell-specific knockout is occurring. If these issues are kept in mind, the only factor that should influence the success of a cell-specific knockout project is the effectiveness of the promoter for driving Cre-recombinase in an appropriate spatial and temporal manner. A. Schematic of the mRNA species generated from the three alleles shown in Figure 1A . The primers used for RT-PCR are shown along with their expected size. B. Aortic RT-PCR products generated from F2 endothelial-null offspring. Lanes 1-4 are RT-PCR products generated from samples where eCre was passed through the male; lanes 5-8 are RT-PCR products generated from samples where eCre was passed through the female. The animal genotype as assessed by tail genomic DNA is indicated below the figure. Total RNA was isolated from thoracic aorta using TriReagent (Molecular Research Center), DNase I treated and re-purified using RNeasy spin columns (Qiagen). cDNA was generated by reverse transcription PCR using Superscript III (Invitrogen). 10ng of reverse transcribed RNA was PCR amplified using primers 1F:
AGACCACTCGCATTCCTTTGACAT and 3R: TCCGGCAGTTAAGATCACACC. 18 (16) 16 (16) 16 ( 
